# A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese

> **NCT07326111** · PHASE4 · RECRUITING · sponsor: **University of Bonn** · enrollment: 198 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS)
- Obesity & Overweight

## Interventions

- **DRUG:** Tirzepatide as an adjunct to lifestyle intervention
- **DRUG:** Placebo as an adjunct to lifestyle intervention

## Key facts

- **NCT ID:** NCT07326111
- **Lead sponsor:** University of Bonn
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07326111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07326111, "A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07326111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*